SpringWorks Therapeutics (SWTX) saw the biggest retail follower increase among biotech stocks last week on Stocktwits, even ...

While the company is in discussions to acquire SpringWorks, it did not elaborate on these talks in its earnings call.

We recently published an article titled Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025. In this article, we are ...

Our analysis of options history for SpringWorks Therapeutics SWTX revealed 9 unusual trades. Delving into the details, we ...

Barclays analyst Peter Lawson says SpringWorks Therapeutics (SWTX) this morning cancelled from the firm’s conference next week, following ...

If you buy and hold a stock for many years, you'd hope to be making a profit. But more than that, you probably want ...

根据监管文件显示，SpringWorks Therapeutics, Inc.（NASDAQ:SWTX）首席运营官Edris Badreddin于2025年3月3日出售了大量公司普通股。Badreddin以每股53.12美元至56.20美元的价格出售了20,000股，交易总额约为1,084,592美元。在SWTX过去六个月股价上涨26%且保持93%高毛利率的强劲势头下完成了此次交易。根据 ...

On February 10, 2025, the Group confirmed advanced discussions about a potential acquisition of SpringWorks Therapeutics ( SWTX ), Inc., USA. At the time of the preparation of the Consolidated ...

Oppenheimer Asset Management Inc. lessened its stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 6.2% in ...

Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the application of a medicine approach to acquiring, developing, and commercializing medicines.

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Get Free Report) saw some unusual options trading on Thursday. Traders acquired 13,068 call options on the stock. This is an increase of 223% compared to ...

根据提交给美国证券交易委员会的文件显示，SpringWorks Therapeutics, Inc. (NASDAQ: SWTX )的首席执行官Islam Saqib最近进行了一系列股票交易。3月3日，Saqib通过多笔交易共计出售了48,000股公司普通股。这些股票的售价在每股52.97美元至56.89美元之间，总价值约266万美元。根据 InvestingPro ...